Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page, a minor metadata update that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.2.0 to v3.3.1, with no changes to the study content or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:41:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page; core study details and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:56:47.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No meaningful changes detected on the page; the study details appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:21:08.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated version to v3.2.0; removed the previous v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-05T10:22:51.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version update to v3.1.0 with added contact details (new emails and phone numbers) for Mediclinic-related contacts. Deletion of the old revision v3.0.2. If no further context, these are the key changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:21:31.000Z thumbnail image

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.